These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 22162539

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assessment of the Risk of Hospitalization for Heart Failure With Dipeptidyl Peptidase-4 Inhibitors, Saxagliptin, Alogliptin, and Sitagliptin in Patients With Type 2 Diabetes, Using an Alternative Measure to the Hazard Ratio.
    Kaneko M, Narukawa M.
    Ann Pharmacother; 2017 Jul; 51(7):570-576. PubMed ID: 28622738
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].
    Filippatos TD, Athyros VG, Elisaf MS.
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):787-812. PubMed ID: 24746233
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE, Salsali A.
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [Abstract] [Full Text] [Related]

  • 26. Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes mellitus: a matching-adjusted indirect comparison of randomized trials.
    Signorovitch JE, Wu EQ, Swallow E, Kantor E, Fan L, Gruenberger JB.
    Clin Drug Investig; 2011 Apr; 31(9):665-74. PubMed ID: 21819162
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose.
    Nomoto H, Kimachi K, Miyoshi H, Kameda H, Cho KY, Nakamura A, Nagai S, Kondo T, Atsumi T.
    Endocr J; 2017 Apr 29; 64(4):417-424. PubMed ID: 28260702
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
    Chen YW, Wang JS, Sheu WH, Lin SY, Lee IT, Song YM, Fu CP, Lee CL.
    PLoS One; 2017 Apr 29; 12(2):e0171753. PubMed ID: 28182722
    [Abstract] [Full Text] [Related]

  • 33. Effects of vildagliptin versus saxagliptin on daily acute glucose fluctuations in Chinese patients with T2DM inadequately controlled with a combination of metformin and sulfonylurea.
    Xiaoyan C, Jing W, Xiaochun H, Yuyu T, Shunyou D, Yingyu F.
    Curr Med Res Opin; 2016 Jun 29; 32(6):1131-6. PubMed ID: 26950829
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.
    Langley AK, Suffoletta TJ, Jennings HR.
    Pharmacotherapy; 2007 Aug 29; 27(8):1163-80. PubMed ID: 17655515
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [New blood glucose-lowering drugs in type 2 diabetes: a review of the literature].
    Kleefstra N, van Hateren KJ, Houweling ST, Verhoeven S, Kooy A, Goudswaard AN, Bilo HJ.
    Ned Tijdschr Geneeskd; 2010 Aug 29; 154():A886. PubMed ID: 20298625
    [Abstract] [Full Text] [Related]

  • 40. Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
    Kothny W, Lukashevich V, Foley JE, Rendell MS, Schweizer A.
    Diabetologia; 2015 Sep 29; 58(9):2020-6. PubMed ID: 26067186
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.